Sarcopenia: A Time for Action. An SCWD Position Paper

Area of Science:

• Gerontology
• Muscle Physiology
• Clinical Nutrition

Background:

• Sarcopenia definition evolved from "muscle loss" (1988) to include low muscle mass and function (2010).
• Primary sarcopenia is age-related; secondary sarcopenia is disease-related (e.g., cancer, COPD, heart failure).
• Current research explores ultrasound and creatine dilution for assessment, with ongoing debate on reproducibility.

Purpose of the Study:

• To provide recommendations on sarcopenia diagnosis and management.
• To highlight the importance of recognizing both age-related and disease-related sarcopenia.
• To advocate for increased clinical research in sarcopenia measurement and treatment.

Main Methods:

• Utilizing consensus recommendations for screening (SARC-F) and diagnosis (grip strength, chair stand, DXA).
• Reviewing existing literature on sarcopenia definitions and management strategies.
• Incorporating expert opinion from the Society of Sarcopenia, Cachexia and Wasting Disorders.

Main Results:

• Recommended screening via SARC-F, with formal diagnosis using grip strength/chair stand and DXA.
• Management guidelines emphasize resistance exercise and protein intake (1-1.5 g/kg/day).
• Limited evidence supports vitamin D or anabolic steroids; underlying disease treatment is crucial for secondary sarcopenia.

Conclusions:

• Early detection and management of sarcopenia are vital for primary care professionals.
• Addressing risk factors like physical inactivity and sedentary behavior is essential.
• Further research is needed to refine muscle mass assessment and optimize sarcopenia management strategies.